Erythropoietic protoporphyria (EPP) (MIM 177000) is an inherited disease due to partial deficiency of ferrochelatase (FECH; EC 4.99.1.1.), the last enzyme in the heme biosynthetic pathway. FECH is located on the mitochondrial inner membrane and catalyzes the insertion of ferrous iron into protoporphyrin IX (PPIX) to form heme. Chronic, progressive, and irreversible cholestatic liver failure occurs in about 3% of EPP patients and results in the need for liver transplantation.
1 x 1 Schneider-Yin, X., Gouya, L., Meier-Weinand, A. et al. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr. 2000; 159: 719–725 Crossref | PubMed | Scopus (52) | Google Scholar See all References Although EPP is generally an indolent disease manifested mainly by photosensitivity, biochemical evidence of liver dysfunction may occur in 10% to 20% of patients. Many patients with EPP develop gallstones containing PPIX (for review see Puy et al
2 x 2 Puy, H., Gouya, L., and Deybach, J.C. Porphyrias. Lancet. 2010; 375: 924–937 Abstract | Full Text | Full Text PDF | PubMed | Scopus (299) | Google Scholar See all References ). The mode of inheritance of EPP is complex, with incomplete penetrance of the disease and considerable variability in clinical expression.
3 x 3 Gouya, L., Martin-Schmitt, C., Robreau, A.M. et al. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet. 2006; 78: 2–14 Abstract | Full Text | Full Text PDF | PubMed | Scopus (116) | Google Scholar See all References FECH deficiency in bone marrow erythroid cells is responsible for a mild microcytic anemia.
4 x 4 Delaby, C., Lyoumi, S., Ducamp, S. et al. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand). 2009; 55: 45–52 PubMed | Google Scholar See all References Accumulation of PPIX in bone marrow erythroid cells leads to high levels of PPIX in plasma, skin, bile, and feces.
4 x 4 Delaby, C., Lyoumi, S., Ducamp, S. et al. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand). 2009; 55: 45–52 PubMed | Google Scholar See all References
, 5 x 5 Lyoumi, S., Abitbol, M., Andrieu, V. et al. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice. Blood. 2007; 109: 811–818 Crossref | PubMed | Scopus (45) | Google Scholar See all References PPIX is a hydrophobic compound and is removed from the body via the liver where it is secreted into the bile and eliminated in the feces. Accumulation of PPIX in the liver causes cholestasis and liver fibrosis.